Stocks Technology PALX
OTC · TechnologyPalomino Laboratories Inc. (PALX)
It posted a net loss of $5.2M. At June 30, 2026 it held $19.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about Palomino Laboratories Inc.
- Net worth
- Palomino Laboratories Inc. has a market value (market cap) of $386.9M at the latest share price, and shareholders' equity of $20.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $1.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Palomino Laboratories Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Palomino Laboratories Inc. does
Palomino Laboratories Inc. is registered with the SEC under industry code SIC 3674 (Semiconductors & Related Devices). Its shares trade on OTC under the ticker PALX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$3.2M | -$0.47 | n/a |
| 2024 | n/a | -$16.2K | -$0.01 | n/a |
| 2023 | n/a | -$83.9K | -$0.01 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Palomino Laboratories Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 28, 2026Preliminary proxy statement PRE 14A
- August 21, 2026Activist stake changed SCHEDULE 13D/A
- August 5, 2026
- August 5, 2026
- July 16, 2026
- May 15, 2026
- May 5, 2026
- April 24, 2026
- April 9, 2026Other event 8-K
- March 31, 2026
Insider trades
What the people running Palomino Laboratories Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 31, 2026 | Ogawa RichardSecretary, Director | Other change | 120,000 | $616.8K |
| April 20, 2026 | Denbaars StevenDirector | Bought | 12,500 | $50K |
| April 20, 2026 | Ogawa RichardSecretary, Director | Bought | 12,500 | $50K |
Who owns PALX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Shealy Jeffrey B.13D, may seek influence | 23.8% | October 27, 2025 |
| Matthew Eitner13D, may seek influence with 1 related filers | 23% | October 6, 2025 |
| Steven DenBaars13D, may seek influence | 9.4% | October 7, 2025 |
| Richard Ogawa13D, may seek influence | 6.9% | August 21, 2026 |
Largest institutional holders
Insiders
2 insiders reported holding 3,645,000 shares in total, about $51M at the last price.
| Holder | Shares |
|---|---|
| Ogawa RichardSecretary, Director | 1,882,500 |
| Denbaars StevenDirector | 1,762,500 |
Questions about PALX
What does Palomino Laboratories Inc. do?
Palomino Laboratories Inc. is a company in the Technology sector, listed on OTC as PALX. Its shares trade on OTC under the ticker PALX.
What is Palomino Laboratories Inc.'s net worth?
Palomino Laboratories Inc. has a market value (market cap) of $386.9M at the latest share price, and shareholders' equity of $20.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Palomino Laboratories Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $5.2M.
When did Palomino Laboratories Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the preliminary proxy statement from September 28, 2026.
When is Palomino Laboratories Inc.'s next earnings report?
Palomino Laboratories Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare PALX with
Follow PALX
Get an email when Palomino Laboratories Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Palomino Laboratories Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.